SCHEMBL11301804

SCHEMBL11301804

C[C@H]1NC(=O)C[C@@H]1N(c1ccc(Cl)cc1)c1ccc(C(=O)NO)cc1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ HDAC8 Q9BY41 11/20 0.40
▸ HDAC1 Q13547 13/20 0.39
▸ HDAC6 Q9UBN7 12/20 0.39
▸ FLT1 P17948 1/20 0.38
▸ FLT4 P35916 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ HDAC2 Q92769 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301806 1.00 ALDH1A1 (0.41) ALDH1A1POLBTDP1HDAC8HDAC1
SCHEMBL11298688 0.79 HDAC8 (0.42) ALDH1A1POLBTDP1HDAC8HDAC1
SCHEMBL11303497 0.76 HDAC8 (0.46) ALDH1A1POLBTDP1HDAC8HDAC1
SCHEMBL11301754 0.71 PSEN1 (0.42) ALDH1A1POLBTDP1HDAC8HDAC1
SCHEMBL11300763 0.69 HDAC8 (0.42) HDAC8KMT2A
SCHEMBL202512 0.69 HDAC1 (0.65) ALDH1A1HDAC8HDAC1HDAC6FLT1
SCHEMBL11303321 0.66 HDAC8 (0.44) HDAC8HDAC1HDAC6HDAC2
SCHEMBL11299454 0.65 HDAC1 (0.44) ALDH1A1POLBTDP1HDAC8HDAC1
SCHEMBL11297461 0.64 HDAC8 (0.37) HDAC8HDAC1HDAC6HDAC2KMT2A
SCHEMBL11297190 0.64 HDAC6 (0.44) HDAC8HDAC1HDAC6HDAC2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
Send feedback